Chione Ltd has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a sale of 16 shares of Acrivon Therapeutics, Inc. ($ACRV) on June 26, 2023.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Chione Ltd | TenPercentOwner | S | Common Stock | 16 | $12.93 | 3,848,632.0000 | 0 | 0.00% | 0.00% |
| June 15, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Chione Ltd | TenPercentOwner | S | Common Stock | 2056 | $12.14 | 3,848,648.0000 | 0 | 0.05% | 0.00% |
| June 12, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Chione Ltd | TenPercentOwner | S | Common Stock | 2000 | $12.34 | 3,854,597.0000 | 0 | 0.05% | 0.00% |
| June 13, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Chione Ltd | TenPercentOwner | S | Common Stock | 3000 | $12.30 | 3,851,597.0000 | 0 | 0.08% | 0.00% |
| June 14, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Chione Ltd | TenPercentOwner | S | Common Stock | 893 | $12.13 | 3,850,704.0000 | 0 | 0.02% | 0.00% |